Streetbeat News

Earnings

PSQH

PSQ Holdings, Inc. (PSQH) reported a Q3 loss of $0.41 per share, slightly worse than the Zacks Consensus Estimate of a $0.40 loss. However, this is an improvement from the $0.49 loss per share reported a year ago. The company exceeded revenue estimates.

Portfolio Pulse from

November 13, 2024 | 12:15 am

CXAI

CXApp Inc. (CXAI) held its Q3 2024 earnings call, discussing financial results and company performance. Key participants included CEO Khurram Sheikh and CFO Joy Mbanugo.

Portfolio Pulse from

November 13, 2024 | 12:15 am

CART

Maplebear (CART) released its Q3 earnings, providing insights into its performance for the quarter ending September 2024. The report suggests comparing key metrics against Wall Street estimates and previous year figures.

Portfolio Pulse from

November 13, 2024 | 12:15 am

PRTA

Prothena (PRTA) reported a Q3 loss of $1.10 per share, which was better than the Zacks Consensus Estimate of a $1.18 loss. However, the company missed revenue estimates.

Portfolio Pulse from

November 13, 2024 | 12:15 am

EVCM

EverCommerce (EVCM) reported a Q3 loss of $0.05 per share, which was larger than the expected loss of $0.01 per share. However, the company exceeded revenue estimates.

Portfolio Pulse from

November 13, 2024 | 12:15 am

INTZ

Intrusion Inc. (INTZ) reported a Q3 loss of $0.35 per share, which was better than the Zacks Consensus Estimate of a $0.42 loss. However, the company lagged in revenue estimates.

Portfolio Pulse from

November 13, 2024 | 12:00 am

PXLW

Pixelworks (PXLW) reported a Q3 loss of $0.12 per share, slightly better than the Zacks Consensus Estimate of a $0.13 loss. This is a larger loss compared to $0.10 per share a year ago.

Portfolio Pulse from

November 13, 2024 | 12:00 am

RPAY

Repay Holdings (RPAY) reported Q3 earnings of $0.23 per share, matching the Zacks Consensus Estimate and showing an increase from $0.21 per share a year ago.

Portfolio Pulse from

November 13, 2024 | 12:00 am

ICUI

ICU Medical (ICUI) reported Q3 earnings of $1.59 per share, surpassing the Zacks Consensus Estimate of $1.25 per share. This is a slight increase from the $1.57 per share reported a year ago.

Portfolio Pulse from

November 13, 2024 | 12:00 am

STIM

Neuronetics, Inc. (NASDAQ: STIM) issued a correction regarding their financial outlook, stating they expect to achieve cash flow breakeven by Q3 2025, not Q2 2025, as previously reported.

Portfolio Pulse from

November 13, 2024 | 12:00 am